000 | 01648 a2200469 4500 | ||
---|---|---|---|
005 | 20250517154733.0 | ||
264 | 0 | _c20170914 | |
008 | 201709s 0 0 eng d | ||
022 | _a1464-3405 | ||
024 | 7 |
_a10.1016/j.bmcl.2017.05.018 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMould, Daniel P | |
245 | 0 | 0 |
_aDevelopment of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1. _h[electronic resource] |
260 |
_bBioorganic & medicinal chemistry letters _c07 2017 |
||
300 |
_a3190-3195 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aB7-2 Antigen _xmetabolism |
650 | 0 | 4 | _aBinding Sites |
650 | 0 | 4 | _aCatalytic Domain |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aHalf-Life |
650 | 0 | 4 |
_aHistone Demethylases _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInhibitory Concentration 50 |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMolecular Docking Simulation |
650 | 0 | 4 |
_aPyrazoles _xchemical synthesis |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 | _aSurface Plasmon Resonance |
700 | 1 | _aBremberg, Ulf | |
700 | 1 | _aJordan, Allan M | |
700 | 1 | _aGeitmann, Matthis | |
700 | 1 | _aMaiques-Diaz, Alba | |
700 | 1 | _aMcGonagle, Alison E | |
700 | 1 | _aSmall, Helen F | |
700 | 1 | _aSomervaille, Tim C P | |
700 | 1 | _aOgilvie, Donald | |
773 | 0 |
_tBioorganic & medicinal chemistry letters _gvol. 27 _gno. 14 _gp. 3190-3195 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmcl.2017.05.018 _zAvailable from publisher's website |
999 |
_c27211524 _d27211524 |